Neuroendocrinology News

Patients with neuroendocrine tumors who have undergone iodine-131–metaiodobenzylguanidine therapy experience respectable rates of survival, but a minority develops hematological pathologies in long-term follow-up, according to research presented at the Society for Endocrinology BES 2012 meeting.

Certain factors were associated with a greater probability of neuroendocrine tumor progression, according to an evaluation of Phase 3 study results.

Aryl-hydrocarbon receptor interacting protein genetic testing should be limited to patients younger than age 40 years who are diagnosed with apparently sporadic large pituitary adenomas, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Transsphenoidal surgery was associated with long-term cure rates of more than 70% in patients with Cushing’s disease, according to researchers from the University of Birmingham in England.

SAN FRANCISCO — Researchers identified that certain factors were associated with a greater probability of neuroendocrine tumor progression, according to data presented at the 2012 ASCO Gastrointestinal Cancers Symposium.

When surgical or medical treatments fail, radiation therapy may be the best alternative for managing pituitary adenomas in certain patients. In a recently published paper in the Journal of Clinical Endocrinology & Metabolism, reviewers discuss different options and potential adverse events associated with radiation therapy.

A team of geneticists in Montreal made an unexpected discovery on hormone secretion: They found that, contrary to previous belief, pituitary cells are organized in structured networks.

ENDO 2011

ENDO 2011

Society for Endocrinology BES 2011